Veracyte Stock Soars to 52-Week High, Reaching $46.12 - MSN

Veracyte Inc . (NASDAQ:VCYT), a pioneering genomic diagnostics company with a market capitalization of $3.57 billion, has reached a new 52-week high, with its stock price climbing to …

CouponFollow Extension

$46.12
OFF

Veracyte Stock Soars To 52-Week High, Reaching $46.12 - MSN

3 weeks from now

Veracyte Inc . (NASDAQ:VCYT), a pioneering genomic diagnostics company with a market capitalization of $3.57 billion, has reached a new 52-week high, with its stock price climbing to …

msn.com

$46.12
OFF

Veracyte Stock Soars To 52-Week High, Reaching $46.12

3 weeks from now

4 days ago · Veracyte Inc . (NASDAQ: VCYT), a pioneering genomic diagnostics company with a market capitalization of $3.57 billion, has reached a new 52-week high, with its stock price …

investing.com

$46.12
OFF

Veracyte Stock Soars To 52-Week High, Reaching $46.12

3 weeks from now

4 days ago · Veracyte Inc . (NASDAQ: VCYT), a pioneering genomic diagnostics company with a market capitalization of $3.57 billion, has reached a new 52-week high, with its stock price …

investing.com

$46.12
OFF

Veracyte Stock Soars To 52-Week High, Reaching $46.12

3 weeks from now

4 days ago · Veracyte Inc . (NASDAQ: VCYT), a pioneering genomic diagnostics company with a market capitalization of $3.57 billion, has reached a new 52-week high, with its stock price …

investing.com

$35.52
OFF

Veracyte Stock Soars To 52-week High, Hits $35.52 - Investing.com

3 weeks from now

Nov 5, 2024 · Veracyte Inc (NASDAQ: VCYT) stock has reached a new 52-week high, touching $35.52, marking a significant milestone for the genomic diagnostics company.This peak …

investing.com

4%
OFF

Veracyte, Inc. (VCYT) Hit A 52 Week High, Can The Run Continue?

3 weeks from now

Aug 14, 2024 · Have you been paying attention to shares of Veracyte (VCYT)?Shares have been on the move with the stock up 27.4% over the past month. The stock hit a new 52-week high …

yahoo.com

$41.46
OFF

Veracyte Stock Soars To 52-Week High, Hits $41.46 - Investing.com

3 weeks from now

Nov 26, 2024 · Veracyte Stock Soars to 52-Week High, Hits $41.46. View all comments (0) 0. VCYT- ... reaching $425.33 million. This growth is even more pronounced in the quarterly …

investing.com

4%
OFF

Veracyte, Inc. (VCYT) Hit A 52 Week High, Can The Run Continue?

3 weeks from now

Aug 14, 2024 · Shares have been on the move with the stock up 27.4% over the past month. The stock hit a new 52-week high of $32.86 in the previous session. Veracyte has gained 18.3% s

nasdaq.com

$41.46
OFF

Veracyte Stock Soars To 52-Week High, Hits $41.46

3 weeks from now

Veracyte Inc . (NASDAQ: VCYT) stock has reached a notable milestone, soaring to a 52-week high of $41.46.This peak reflects a significant uptrend for the genomic diagnostics company, …

investing.com

$33.35
OFF

Veracyte Stock Soars To 52-week High, Hits $33.35 - Investing.com …

3 weeks from now

Sep 16, 2024 · Veracyte Inc (NASDAQ: VCYT) stock has reached a new 52-week high, touching $33.35 amidst a year marked by robust growth.The company, known for its genomic …

investing.com

$41.46
OFF

Veracyte Stock Soars To 52-Week High, Hits $41.46

3 weeks from now

Nov 26, 2024 · Veracyte Inc . (NASDAQ: VCYT) stock has reached a notable milestone, soaring to a 52-week high of $41.46.This peak reflects a significant uptrend for the genomic …

investing.com

$35.52
OFF

Veracyte Stock Soars To 52-week High, Hits $35.52 - Investing.com …

3 weeks from now

Nov 5, 2024 · Veracyte Inc (NASDAQ: VCYT) stock has reached a new 52-week high, touching $35.52, marking a significant milestone for the genomic diagnostics company.This peak …

investing.com

$29.42
OFF

Veracyte Stock Soars To 52-Week High, Reaching $29.42

3 weeks from now

Aug 7, 2024 · Veracyte Inc . (NASDAQ: VCYT), a pioneering genomic diagnostics company, has achieved a significant milestone as its stock price soared to a 52-week high of $29.42.This …

investing.com

$3
OFF

Veracyte: Il Titolo Raggiunge Un Nuovo Massimo Di 52 Settimane A …

3 weeks from now

4 days ago · Veracyte Inc. (VCYT), un'azienda pionieristica nel campo della diagnostica genomica con una capitalizzazione di mercato di $3,57 miliardi, ha raggiunto un nuovo massimo di 52 …

investing.com

$44.48
OFF

Veracyte Stock Soars To 52-week High Of $44.48 Amid Robust Growth

3 weeks from now

Dec 4, 2024 · In a remarkable display of market confidence, Veracyte Inc (NASDAQ: VCYT) stock has reached a 52-week high, touching $44.48, with a market capitalization of $3.44 …

investing.com

$32.88
OFF

Veracyte Stock Soars To 52-week High, Hits $32.88 - Investing.com …

3 weeks from now

Aug 15, 2024 · Veracyte stock soars to 52-week high, hits $32.88

investing.com

$29.42
OFF

Veracyte Stock Soars To 52-Week High, Reaching $29.42

3 weeks from now

Aug 7, 2024 · Veracyte Stock Soars to 52-Week High, Reaching $29.42

investing.com

FAQs about Veracyte Stock Soars to 52-Week High, Reaching $46.12 - MSN Coupon?

Where can I buy Veracyte stock?

Shares of VCYT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Veracyte own? ...

How much of Veracyte's stock have insiders sold?

In the past three months, Veracyte insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,008,297.00 in company stock. Only 1.30% of the stock of Veracyte is held by insiders. Read more about Veracyte's insider trading history. ...

What are the Zacks rank style scores for Veracyte?

The idea behind the style scores is to help investors pick the most appropriate Zacks Rank stocks based on their individual investment style. Veracyte has a Value Score of F. The stock's Growth and Momentum Scores are A and A, respectively, giving the company a VGM Score of B. ...

How much will Veracyte earn In fiscal year?

For the current fiscal year, Veracyte is expected to post earnings of $0 per share on $437.35 million in revenues. This represents a 100% change in EPS on a 21.13% change in revenues. For the next fiscal year, the company is expected to earn $0.18 per share on $460.69 million in revenues. ...

How did Veracyte perform in Q3 2024?

The company reported record revenues of $115.9 million in Q3 2024, marking a significant 29% increase from the previous year, primarily driven by its Decipher and Afirma tests. Veracyte's total revenue guidance for 2024 was also raised, reflecting confidence in its ongoing growth and market expansion initiatives. ...

How did Veracyte (vcyt) perform in the quarter?

Veracyte, Inc. (NASDAQ:VCYT) announced its earnings results on Wednesday, November, 6th. The biotechnology company reported $0.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.03 by $0.16. The business's quarterly revenue was up 28.6% compared to the same quarter last year. ...